| 1 |
The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones
|
|
|
|
BASE
|
|
Show details
|
|
|
| 3 |
Contributing factors to improved speech perception in children using the nucleus 22-channel cochlear prosthesis
|
|
|
|
BASE
|
|
Show details
|
|
|
| 4 |
Multicenter evaluations of speech perception in adults and children with the nucleus (cochlear) 22-channel cochlear implant
|
|
|
|
Abstract:
The Nucleus 22-channel cochlear implant has been implanted in over 10,500 patients in 79 countries. and used for more than 25 languages. It arose as a result of our early physiological, behavioral and biological research on experimental animals. The historical development of the Nucleus device has been outlined in detail by Clark. Our ongoing research has led to improvements in the way speech is processed with the 22-channel device that are now resulting in improved speech perception for profoundly totally deaf people that is, on average, better than the speech perception obtained by many deaf people with hearing aids. The multiple-channel cochlear implant was first approved by the US Food and Drug Administration (FDA) for use in postlinguistically deaf adults in 1985. It was subsequently approved for use in children in 1990. The proportion of children (18 years of age and under) to have now received it is approximately 439C (4,500 out of 10.500). In evaluating improvements in speech processing it is important to design well-controlled studies, and a number of important ones which have previously been published are summarized in this paper. In addition, speech perception results for all the Nucleus speech processing strategies have been obtained four to six months postoperatively from unselected patients presenting to the Cochlear Implant Clinic at the Royal Victorian Eye & Ear Hospital (RVEEH), Melbourne, and are presented in this paper. As results can vary greatly with different durations of experience it is essential to make comparisons at the same time postoperatively. These clinical data are the most complete to date for comparing the Nucleus speech processing strategies. ; 10-14 June
|
|
Keyword:
Nucleus 22-channel cochlear implant; otolaryngology; otology
|
|
URL: http://hdl.handle.net/11343/26938
|
|
BASE
|
|
Hide details
|
|
|
| 5 |
Habilitation issues in the management of children using the cochlear multiple-channel cochlear prosthesis
|
|
|
|
BASE
|
|
Show details
|
|
|
| 6 |
Preoperative residual hearing as a predictor of postoperative speech scores for adult cochlear implant users [Abstract]
|
|
|
|
BASE
|
|
Show details
|
|
|
| 7 |
Clinical comparison of open-set speech perception with MSP and WSPIII speech processors and preliminary results for the new SPEAK processor [Abstracts]
|
|
|
|
BASE
|
|
Show details
|
|
|
| 8 |
The development of the Melbourne/Cochlear multiple-channel cochlear implant for profoundly deaf children
|
|
|
|
BASE
|
|
Show details
|
|
|
| 9 |
Revised selection criteria for the multiple-channel cochlear implant
|
|
|
|
BASE
|
|
Show details
|
|
|
| 10 |
Criteria of suitability for cochlear implantation [Abstract]
|
|
|
|
BASE
|
|
Show details
|
|
|
| 11 |
The histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient: correlation with psychophysics and speech perception results
|
|
|
|
BASE
|
|
Show details
|
|
|
| 12 |
Preliminary results for the Cochlear Corporation multielectrode intracochlear implant in six prelingually deaf patients
|
|
|
|
BASE
|
|
Show details
|
|
|
| 13 |
Clinical trial of a multiple-channel cochlear prosthesis: an initial study in four patients with profound total hearing loss
|
|
|
|
BASE
|
|
Show details
|
|
|
|
|
